|
HZNP
|
Horizon Pharma, Inc.
|
5.64%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
4.56%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
4.35%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
3.71%
|
US
|
NASDAQ
|
|
1177
|
Sino Biopharmaceutical Ltd
|
3.59%
|
HK
|
HK
|
|
UTHR
|
United Therapeutics Corporation
|
3.54%
|
US
|
NASDAQ
|
|
ABBV
|
AbbVie Inc.
|
3.45%
|
US
|
NYSE
|
|
IPN
|
Ipsen SA
|
3.44%
|
FR
|
PA
|
|
INCY
|
Incyte Corporation
|
3.39%
|
US
|
NASDAQ
|
|
NVS
|
Novartis AG
|
3.39%
|
US
|
NYSE
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
3.36%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
3.28%
|
US
|
NASDAQ
|
|
PHMMF
|
Pharma Mar S.A.U.
|
3.18%
|
US
|
OTC
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
3.14%
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
3.13%
|
US
|
NYSE
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
3.11%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
3.07%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
2.99%
|
US
|
NASDAQ
|
|
SOBI
|
Swedish Orphan Biovitrum AB (publ)
|
2.93%
|
SE
|
ST
|
|
ROG
|
Roche Holding AG
|
2.86%
|
CH
|
SW
|